The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - ORIC Pharmaceuticals
Stock and Other Ownership Interests - ORIC Pharmaceuticals
An open-label phase Ib study of ORIC-101 in combination with enzalutamide in patients with metastatic prostate cancer progressing on enzalutamide.
 
Neal D. Shore
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Merck; Myovant Sciences; Pfizer; Tolmar
Speakers' Bureau - Bayer; Dendreon; Janssen
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Bayer; Janssen Biotech; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Sanofi; Tolmar
Research Funding - Astellas Pharma; Bayer; Janssen; Sanofi; Tolmar
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Sanofi; Tolmar
 
Rupal Patel
Employment - ORIC Pharmaceuticals
Stock and Other Ownership Interests - ORIC Pharmaceuticals
 
Rongda Xu
Employment - ACEA Therapeutics; ORIC Pharmaceuticals
Stock and Other Ownership Interests - ACEA Therapeutics; ORIC Pharmaceuticals
Consulting or Advisory Role - FronThera Pharmaceuticals
 
Ann Johnson
No Relationships to Disclose
 
Pratik S. Multani
Employment - Ignyta
Leadership - Ignyta
Stock and Other Ownership Interests - Ignyta
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Blue Earth Diagnostics; Endocyte; ORIC Pharmaceuticals; Tokai Pharmaceuticals; Tolmar
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Endocyte
 
Wassim Abida
Honoraria - CARET
Consulting or Advisory Role - Clovis Oncology; Janssen; MORE Health; ORIC Pharmaceuticals
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - Clovis Oncology; GlaxoSmithKline; ORIC Pharmaceuticals